GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » YoY EBITDA Growth

Shanghai Universal Biotech Co (SZSE:301166) YoY EBITDA Growth : -788.24% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Universal Biotech Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Shanghai Universal Biotech Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was -788.24%.

Shanghai Universal Biotech Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥-0.23.

Shanghai Universal Biotech Co YoY EBITDA Growth Historical Data

The historical data trend for Shanghai Universal Biotech Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Universal Biotech Co YoY EBITDA Growth Chart

Shanghai Universal Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial 41.12 25.02 39.65 -25.99 -59.68

Shanghai Universal Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.46 -111.60 -92.73 -61.43 -788.24

Shanghai Universal Biotech Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Shanghai Universal Biotech Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.658-1.632)/ | 1.632 |
=-59.68 %

Shanghai Universal Biotech Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0.234-0.034)/ | 0.034 |
=-788.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Universal Biotech Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Shanghai Universal Biotech Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Universal Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » YoY EBITDA Growth
Comparable Companies
SHSE:688137 SZSE:002873 SZSE:000518 SHSE:688098 SZSE:002566 SZSE:300878 SHSE:605177 BJSE:837344 SZSE:002286 SZSE:301258 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
No. 1690 Kongjiang Road, Room 1505, Yangpu District, Shanghai, CHN, 200082
Website
https://www.univ-bio.com
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.
Executives
Leng Zhao Wen Director

Shanghai Universal Biotech Co Headlines

No Headlines